Atlas Trials

Comparison of the Efficacy and Safety of Tiropramide and Octylonium in the Treatment of Irritable Bowel Syndrome

Clinical trial NCT01629212 · UNKNOWN

Trial details

NCT number
NCT01629212
Sponsor
Daewoong Pharmaceutical Co. LTD.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Irritable Bowel Syndrome
Start date
2011-12-01
Primary completion
2013-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.